Back to top
more

Anika Therapeutics (ANIK)

(Delayed Data from NSDQ)

$8.35 USD

8.35
123,166

-0.42 (-4.79%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $8.38 +0.03 (0.36%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (143 out of 246)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Cytori Scleroderma Study Two-Year Follow-Up Data Published

by Zacks Equity Research

Cytori Therapeutics (CYTX) announced the publication of two year follow-up data from the scleroderma study.

    Zacks Equity Research

    Aimmune Closes Enrolment in Phase III Peanut Allergy Study

    by Zacks Equity Research

    Aimmune Therapeutics, Inc. (AIMT) announced that it has completed global enrollment in the phase III PALISADE study on AR101

      Zacks Equity Research

      PhaseRx Soars on Orphan Drug Status for Rare Liver Disease

      by Zacks Equity Research

      PhaseRx (PZRX) received Orphan Drug status from the FDA for PRX-OTC for the treatment of rare liver disorder.

        Zacks Equity Research

        Foamix Completes Enrolment in Phase III Acne Drug Studies

        by Zacks Equity Research

        Foamix Pharmaceuticals Ltd. (FOMX) announced that it has completed patient enrollment in two phase III studies

          Zacks Equity Research

          Zacks.com featured highlights: Chemours, Matador Resources, Best Buy, Anika Therapeutics and McDermott International

          by Zacks Equity Research

          Zacks.com featured highlights: Chemours, Matador Resources, Best Buy, Anika Therapeutics and McDermott International

            Tirthankar Chakraborty headshot

            New Strong Buy Stocks for November 16th

            by Tirthankar Chakraborty

            Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday

              Tirthankar Chakraborty headshot

              New Strong Buy Stocks for October 31st

              by Tirthankar Chakraborty

              Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday